Kåre Schultz bliver ny topchef i Lundbeck - Dagens Pharma
Teva seeks CEO replacement as Shultz will retire in 2023: WSJ
Teva CEO Schultz likely won't renew employment contract: reports
Teva CORE | Comprehensive Oncology Reimbursement Expertise
Teva said to 'walk away' from settlement talks in US price-fixing lawsuit | The Times of Israel
Teva hires ex-Novartis executive to succeed CEO Schultz | Reuters
Teva: Er den ulidelige og smertelig ventetid forbi - ProInvestor
Lundbecks nuvarande vd tar över ledarskapet i Teva - LäkemedelsVärlden
Business-update: Kåre Schultz' Teva går fri i enormt milliardsøgsmål – nu banker aktien i vejret
Teva to produce new complex drugs outside Israel - Globes
Teva Accused of Manipulating Patent to Monopolize Inhaler Market
Kåre Schultz er tavs om mulig kontraktforlængelse: “Det skaber bare unødvendige rygter”
Corcept (CORT) Falls on Loss of Korlym Patent Lawsuit to Teva
Teva hires ex-Novartis executive to succeed CEO Schultz | Reuters
Köp Mometasone Teva nässpray 50 mikrogram/dos 60 doser på apotea.se
Teva: Vil tålmodigheden blive belønnet? | Nordnet
Teva Pharmaceuticals scores win in patent infringement suit - NJBIZ
/s3.amazonaws.com/arc-authors/reuters/24e53264-190b-4097-835a-edeca236a9f4.png "Teva hires ex-Novartis executive to succeed CEO Schultz | Reuters")
Teva hires ex-Novartis executive to succeed CEO Schultz | Reuters
FINANS | Seneste nyheder - Nyt fra erhvervslivet - Nyhedsoverblik
